KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Current Assets (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Current Assets for 7 consecutive years, with $643.1 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 2.45% to $643.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $643.1 million through Dec 2025, down 2.45% year-over-year, with the annual reading at $643.1 million for FY2025, 2.45% down from the prior year.
  • Current Assets hit $643.1 million in Q4 2025 for GoodRx Holdings, up from $565.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.1 billion in Q1 2021 to a low of $540.2 million in Q1 2025.
  • Historically, Current Assets has averaged $838.2 million across 5 years, with a median of $886.2 million in 2022.
  • Biggest five-year swings in Current Assets: grew 10.33% in 2023 and later crashed 35.32% in 2024.
  • Year by year, Current Assets stood at $1.1 billion in 2021, then decreased by 15.53% to $919.7 million in 2022, then dropped by 5.1% to $872.8 million in 2023, then dropped by 24.47% to $659.3 million in 2024, then fell by 2.45% to $643.1 million in 2025.
  • Business Quant data shows Current Assets for GDRX at $643.1 million in Q4 2025, $565.5 million in Q3 2025, and $550.6 million in Q2 2025.